OM
Opaleye Management Portfolio holdings
AUM
$494M
This Quarter Return
+6.78%
1 Year Return
+68.17%
3 Year Return
+608.37%
5 Year Return
+807.76%
10 Year Return
+24,567.28%
AUM
$150M
AUM Growth
+$150M
(-6.6%)
Cap. Flow
-$10.5M
Cap. Flow
% of AUM
-6.99%
Top 10 Holdings %
Top 10 Hldgs %
46.24%
Holding
65
New
13
Increased
10
Reduced
12
Closed
16
Top Buys
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$3.29M |
| 2 |
MacroGenics
MGNX
|
$3.02M |
| 3 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$2.52M |
| 4 |
GNMX
Aevi Genomic Medicine, Inc.
GNMX
|
$2.18M |
| 5 |
Iovance Biotherapeutics
IOVA
|
$2.11M |
Top Sells
| 1 |
SAGE
Sage Therapeutics
SAGE
|
$5.29M |
| 2 |
Assertio
ASRT
|
$4.53M |
| 3 |
Geron
GERN
|
$3.87M |
| 4 |
ISEE
IVERIC bio, Inc. Common Stock
ISEE
|
$3.38M |
| 5 |
AMAG
AMAG Pharmaceuticals, Inc.
AMAG
|
$2.39M |
Sector Composition
| 1 | Healthcare | 83.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
51
Assertio
ASRT
$78M
| – | – |
-81,250
| Closed | -$4.53M |
|
|
52
Geron
GERN
$893M
| – | – |
-1,325,000
| Closed | -$3.87M |
|
53
Nektar Therapeutics
NKTR
$543M
| – | – |
-3,333
| Closed | -$688K |
|
54
Prothena Corp
PRTA
$452M
| – | – |
-14,000
| Closed | -$576K |
|
|
SAGE
55
DELISTED
Sage Therapeutics
SAGE
| – | – |
-165,000
| Closed | -$5.29M |
|
56
Travere Therapeutics
TVTX
$1.75B
| – | – |
-150,000
| Closed | -$2.05M |
|
57
Xoma
XOMA
$421M
| – | – |
-67,500
| Closed | -$1.04M |
|
|
ALPN
58
DELISTED
Alpine Immune Sciences, Inc. Common Stock
ALPN
| – | – |
-25,000
| Closed | -$417K |
|
|
NBSE
59
DELISTED
NeuBase Therapeutics, Inc. Common Stock
NBSE
| – | – |
-915
| Closed | -$1.18M |
|
|
ISEE
60
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| – | – |
-80,000
| Closed | -$3.38M |
|
|
AKAO
61
DELISTED
Achaogen, Inc.
AKAO
| – | – |
-255,000
| Closed | -$704K |
|